Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Tonkin

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Journal of Cardiac Failure|October 30, 2003
Why do phase III trials of promising heart failure drugs often fail? The contribution of "regression to the truth"Henry Krum, Andrew Tonkin
American Heart Journal|October 31, 2007
A meta-analysis of the effect of thiazolidinediones on in-stent restenosis after coronary stent implantationLei Chen, Andrew Tonkin
Cardiovascular Drugs and Therapy|October 19, 2011
The MAGIC Study and the gastrointestinal effects of low-dose aspirin : editorial to: "Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study" by H. Origasa et alJohn McNeil, Andrew Tonkin
Heart, Lung & Circulation|December 15, 2005
Relevancy of the National Heart FoundationAndrew Tonkin, Phillip Harris
F1000Prime Reports|March 27, 2014
Treatment of dyslipidemiaAndrew Tonkin, Allison Byrnes
Circulation|July 10, 2013
Put disease prevention firstTom G Briffa, Andrew Tonkin
Australian Family Physician|June 3, 2005
Secondary prevention of CHDMark R Nelson, Andrew Tonkin
Heart, Lung & Circulation|June 9, 2016
Obituary - Henry KrumDavid L Hare, Andrew Tonkin
Australian Family Physician|March 3, 2004
Bush telegraph. Improving outcomes for rural and remote patients with chronic heart failureHenry Krum, Andrew Tonkin, Leon Piterman
Circulation|March 13, 2019
Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease"John Simes, Adrienne Kirby, Andrew Tonkin
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Journal of Cardiac Failure|October 30, 2003
Why do phase III trials of promising heart failure drugs often fail? The contribution of "regression to the truth"Henry Krum, Andrew Tonkin
American Heart Journal|October 31, 2007
A meta-analysis of the effect of thiazolidinediones on in-stent restenosis after coronary stent implantationLei Chen, Andrew Tonkin
Cardiovascular Drugs and Therapy|October 19, 2011
The MAGIC Study and the gastrointestinal effects of low-dose aspirin : editorial to: "Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study" by H. Origasa et alJohn McNeil, Andrew Tonkin
Heart, Lung & Circulation|December 15, 2005
Relevancy of the National Heart FoundationAndrew Tonkin, Phillip Harris
F1000Prime Reports|March 27, 2014
Treatment of dyslipidemiaAndrew Tonkin, Allison Byrnes
Circulation|July 10, 2013
Put disease prevention firstTom G Briffa, Andrew Tonkin
Australian Family Physician|June 3, 2005
Secondary prevention of CHDMark R Nelson, Andrew Tonkin
Heart, Lung & Circulation|June 9, 2016
Obituary - Henry KrumDavid L Hare, Andrew Tonkin
Australian Family Physician|March 3, 2004
Bush telegraph. Improving outcomes for rural and remote patients with chronic heart failureHenry Krum, Andrew Tonkin, Leon Piterman
Circulation|March 13, 2019
Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease"John Simes, Adrienne Kirby, Andrew Tonkin
Pageof 17